Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

ASP4058, a Novel Agonist for Sphingosine 1-Phosphate Receptors 1 and 5, Ameliorates Rodent Experimental Autoimmune Encephalomyelitis with a Favorable Safety Profile.
Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation.
Baseline magnetic resonance imaging of the optic nerve provides limited predictive information on short-term recovery after acute optic neuritis.
Test-retest reliability of four sensory measures in people with multiple sclerosis.
Endogenous antibodies contribute to macrophage-mediated demyelination in a mouse model for CMT1B.
Cerebral tumefactive demyelinating lesions.
Associations of Systemic Diseases with Intermediate Uveitis.
Multiple sclerosis relapse mimicking a transient ischemic attack.
Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.
Effects of prolonged fasting on fatigue and quality of life in patients with multiple sclerosis.
A case-control study of dietary salt intake in pediatric-onset multiple sclerosis.
Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59.
Crying and suicidal, but not depressed. Pseudobulbar affect in multiple sclerosis successfully treated with valproic acid: Case report and literature review.
Modern communication technology skills of patients with multiple sclerosis.
Exposure to UV Wavelengths in Sunlight Suppresses Immunity. To What Extent is UV-induced Vitamin D3 the Mediator Responsible?
MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials.
Interference of upper limb tremor on daily life activities in people with multiple sclerosis.
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.
Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions.
Congenital and Acquired Abnormalities of the Corpus Callosum: A Pictorial Essay.
[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 9. Therapeutic progress in multiple sclerosis and neuromyelitis optica].
PERK Activation Preserves the Viability and Function of Remyelinating Oligodendrocytes in Immune-Mediated Demyelinating Diseases.
Depression as a predictor of occupational transition in a multiple sclerosis cohort.
Ten Years of Proteomics in Multiple Sclerosis.
Disturbed function of the blood-cerebrospinal fluid barrier aggravates neuro-inflammation.

Pages